Sign in
0IL8 Stock Price, Chart, Stats & News
Kyntra Bio, Inc.
Save
Kyntra Bio, Inc. (0IL8) does not currently pay a dividend.
29.32M
Market cap
0.18x
Current P/E
–
Forward P/E
0IL8 chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Kyntra Bio, Inc. is a biopharmaceutical enterprise focused on the entire spectrum of therapeutic innovation, from discovering new compounds to developing and commercializing them. Leveraging profound insights into hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology, the company strives to engineer effective medicinal solutions for anemia, fibrotic conditions, and various forms of cancer. Founded by Thomas B.
Similar securities
Based on sector and market capitalization
Report issue